XML 28 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:
 6 Months Ended
Sep. 30, 2013
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:  
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

2.             EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY:

 

Earnings Per Share

 

A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
September 30

 

For the six months ended
September 30

 

 

 

2013

 

2012

 

2013

 

2012

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Net earnings

 

$

9,864

 

$

16,372

 

$

22,959

 

$

29,571

 

Net gain (loss) attributable to noncontrolling interest

 

25

 

(139

)

(60

)

(273

)

Net earnings attributable to Acxiom

 

$

9,839

 

$

16,511

 

$

23,019

 

$

29,844

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

73,778

 

75,009

 

73,728

 

75,741

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

Net earnings

 

$

0.13

 

$

0.22

 

$

0.31

 

$

0.39

 

Net loss attributable to noncontrolling interest

 

—

 

—

 

—

 

—

 

Net earnings attributable to Acxiom

 

$

0.13

 

$

0.22

 

$

0.31

 

$

0.39

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

73,778

 

75,009

 

73,728

 

75,741

 

Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method

 

2,258

 

2,016

 

2,036

 

1,800

 

Diluted weighted-average shares outstanding

 

76,036

 

77,025

 

75,764

 

77,541

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

Net earnings

 

$

0.13

 

$

0.21

 

$

0.30

 

$

0.38

 

Net loss attributable to noncontrolling interest

 

—

 

—

 

—

 

—

 

Net earnings attributable to Acxiom

 

$

0.13

 

$

0.21

 

$

0.30

 

$

0.38

 

 

As of September 30, 2013, the Company had options and warrants outstanding providing for the purchase of approximately 8.5 million shares of common stock together with restricted stock units relating to 2.2 million shares of stock.  Options, warrants and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

 

 

 

For the quarter ended
September 30

 

For the six months ended
September 30

 

 

 

2013

 

2012

 

2013

 

2012

 

Number of shares outstanding under options, warrants and restricted stock units

 

2,224

 

4,762

 

3,390

 

7,093

 

Range of exercise prices for options and warrants

 

$

21.46-$62.06

 

$

17.76-$62.06

 

$

21.46-$62.06

 

$

15.31-$62.06

 

 

Stockholders’ Equity

 

On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded on December 5, 2011, on May 24, 2012, and again on February 5, 2013.  Under the modified common stock repurchase program, the Company may purchase up to $200.0 million worth of its common stock through the period ending February 5, 2014.  During the six months ended September 30, 2013, the Company repurchased 1.6 million shares of its common stock for $38.8 million.  Through September 30, 2013, the Company had repurchased 12.0 million shares of its stock for $178.8 million, leaving remaining capacity of $21.2 million under the stock repurchase program.

 

Accumulated Other Comprehensive Income

 

The accumulated balances for each component of other comprehensive income are as follows (dollars in thousands):

 

 

 

September 30,
2013

 

March 31,
2013

 

Foreign currency translation

 

$

13,088

 

$

12,175

 

Unrealized loss on interest rate swap

 

(334

)

(752

)

 

 

$

12,754

 

$

11,423